Briefing on the progress of the VascoStem and JointStem development project

The Biostar Stem Cell Research Institute wishes to brief you on the progress of the VascoStem and JointStem R&D project at the General Meeting of Shareholders of Nature Cell on September 11, 2015.

We cordially invite you to the briefing session to be provided with detailed information on progress of the application for the designation of VascoStem as an orphan drug and conditional approval of its application as well as the clinical trial (2b) of JointStem.

• Date & Time: September 11, 2015 (Friday) at 11 AM (following the General Meeting of Shareholders of Nature Cell)
• Venue: #710, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul
• For inquiries, contact us at 02-858-8021 [Administrative Support Team]

Sincerely,

Ra Jeong-chan, the President of the Biostar Stem Cell Research Institute